Yesterdays market: Money leaving the market – High selling pressure
TC2000 McClellan: -88
Stocks above 40PMA T2108: 38
VIX: 25
52 week highs (US common stocks): 161
Seasonality:
The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.
The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.
The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.
Indices:
$SOXX Downtrend
$QQQ: Downtrend
$SPY: Downtrend
$RSP: Downtrend
$DIA: Downtrend
$IWM: Downtrend
$BTC: Downtrend
$SQQQ: Uptrend
$UVIX: Uptrend
$TLT: Downtrend
$USO: Downtrend
$TNX: Uptrend
$GLD: Downtrend
$SLV: Downtrend
$SLX: Downtrend
2%+ sectors yesterday:
None
2%- sectors yesterday:
$TAN -5.17%
$IGV -3.29%
$JETS -2.31%
Main sectors monthly trailing:
Leading – $XLV $XHB
Lagging – $XLE $XLK
Sub sectors monthly trailing:
Leading – $RTH $JETS
Lagging – $TAN $SMH
Bitcoin: 65k ish
Current market themes:
Theme 1: Big Pharma & GLP-1 Defensive Leadership
Catalyst: Investors are moving money out of AI and into steady earners. Lilly’s Q3 sales hit $24.4 billion, about $1.9 billion above forecasts, and AbbVie, Lilly and Gilead are trading at or near record highs.
Sectors: Big pharma, obesity drugs (GLP-1), large-cap biotech, medtech.
Conviction: High. Strong earnings plus a defensive bid while a rate hike is coming.
Ticker
Company
Sector/Industry
Last (13 Nov)
1D %
Market Cap
YTD
Key Catalyst
Analyst Consensus
LLY
Eli Lilly and Company
Pharma / GLP-1
1443.50
1.26
~$1.3T (verify)
verify
Raised 2026 guidance; record highs
verify
ABBV
AbbVie Inc.
Pharma
295.03
0.20
verify
>25%
52-week highs after Q3
verify
JNJ
Johnson & Johnson
Pharma / Medtech
285.75
0.79
verify
verify
Defensive rotation
verify
MRK
Merck & Co., Inc.
Pharma
147.76
0.55
verify
verify
Q3 beat
verify
AMGN
Amgen Inc.
Biotech / Obesity
465.67
-0.30
verify
verify
Obesity pipeline
verify
GILD
Gilead Sciences, Inc.
Biotech
168.08
0.08
verify
verify
Near record highs
verify
AZN
AstraZeneca PLC (ADR)
Pharma
184.45
0.04
verify
verify
Defensive bid
verify
NVO
Novo Nordisk A/S (ADR)
Pharma / GLP-1
41.63
2.41
verify
verify
GLP-1 laggard catch-up
verify
BMY
Bristol-Myers Squibb Company
Pharma
63.43
1.78
verify
verify
Value rotation
verify
PFE
Pfizer Inc.
Pharma
28.89
0.21
verify
verify
Low-valuation defensive
verify
REGN
Regeneron Pharmaceuticals, Inc.
Biotech
955.47
0.45
verify
verify
Pipeline momentum
verify
VRTX
Vertex Pharmaceuticals Incorporated
Biotech
538.60
-0.74
verify
verify
Defensive growth
verify
ISRG
Intuitive Surgical, Inc.
Medtech / Robotics
443.59
0.84
verify
verify
Procedure growth
verify
BSX
Boston Scientific Corporation
Medtech
44.34
0.32
verify
verify
Medtech rotation
verify
VKTX
Viking Therapeutics, Inc.
Biotech / Obesity
29.22
5.95
verify
verify
Oral VK2735 heading to phase III in Q4 2026
verify
ETFs
XLV (188.85), IHE, IBB, XBI
Theme 2: Energy & the Hormuz Risk Premium
Catalyst: Energy is 2026’s best-performing sector, and it was one of the groups investors moved into on Friday. The risk is the oil price: Brent traded above $112 at the start of November, and the slide came on growing hopes for a US-Iran peace deal. Brent is now near $96 and WTI near $88.
Conviction: Medium. It’s an inflation hedge and still a geopolitical hedge, but it depends on what oil does next.
Ticker
Company
Sector/Industry
Last (13 Nov)
1D %
Market Cap
YTD
Key Catalyst
Analyst Consensus
XOM
Exxon Mobil Corporation
Integrated Oil
170.59
0.48
verify
verify
Hormuz headlines; Q3 beat
verify
CVX
Chevron Corporation
Integrated Oil
219.89
1.64
verify
verify
Oil price sensitivity
verify
COP
ConocoPhillips
Oil Producer
142.28
1.59
verify
verify
Crude rebound
verify
EOG
EOG Resources, Inc.
Oil Producer
158.32
1.74
verify
verify
Went into 2026 completely unhedged
verify
OXY
Occidental Petroleum Corporation
Oil Producer
58.75
0.60
verify
verify
Adjusted EPS of $1.91
verify
DVN
Devon Energy Corporation
Oil Producer
46.58
0.76
verify
verify
Crude beta
verify
FANG
Diamondback Energy, Inc.
Oil Producer
184.93
1.50
verify
verify
Permian producer
verify
SLB
SLB N.V.
Oilfield Services
51.63
1.41
verify
verify
International spending
verify
HAL
Halliburton Company
Oilfield Services
33.50
2.26
verify
verify
Oilfield services recovery
verify
BKR
Baker Hughes Company
Oilfield Services / LNG Equipment
49.44
1.19
verify
verify
LNG and power equipment
verify
VLO
Valero Energy Corporation
Refining
379.83
1.30
verify
verify
Refining margins
verify
MPC
Marathon Petroleum Corporation
Refining
414.65
0.44
verify
verify
Refining margins
verify
PSX
Phillips 66
Refining / Midstream
265.98
1.17
verify
verify
Refining plus midstream
verify
LNG
Cheniere Energy, Inc.
LNG Export
308.75
-0.24
verify
verify
Global LNG demand
verify
KGS
Kodiak Gas Services, Inc.
Gas Compression
45.16
1.71
verify
verify
Jumped on a record quarter
verify
ETFs
XLE (64.96), XOP, OIH, VDE
What type of market are we in: [FILL – last: Choppy, Tech remains weak]
Key things for this week: This week is all about Nvidia on Tuesday evening, and it’s an unusual setup. It’s the company’s first report since Jensen Huang resigned as CEO on 12 November, with CFO Colette Kress now interim CEO. The stock had already fallen 29.4% in five weeks with no new results, and its P/E is the lowest since 2019. Nvidia guided to revenue of $108.0bn (plus or minus 2%), almost double the same quarter a year earlier. At the 12 November close it was worth about $4.01 trillion, more than the other 83 companies reporting that week combined, so its numbers and guidance will set the tone for the whole AI and semis complex. Around it, the week is a holiday-shopping test: Home Depot and Disney report Tuesday morning, Target, Lowe’s and TJX on Wednesday morning, and Walmart on Thursday morning. Tariff refunds are a common theme across the retailers. On the macro side, October retail sales land on Tuesday morning and the Fed’s October meeting minutes on Wednesday afternoon. UK CPI is also due this week.
Are breakouts working: No
Are breakouts likely to work for the next 3 – 5 days: No, all indices in downtrends
Are breakdowns likely to work for the next 3 – 5 days: No, not a low risk area with today being day 5 of the down move.
Should I be trading: Quick 5m ROE’s
Todays watchlist (stocks setting up): Nothing at the moment
Fridays market: Money leaving the market – Very high selling pressure
TC2000 McClellan: -37
Stocks above 40PMA T2108: 43
VIX: 23
52 week highs (US common stocks): 208
Seasonality:
The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.
The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.
The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.
Indices:
$SOXX No trend
$QQQ: No trend
$SPY: No trend
$RSP: No trend
$DIA: No trend
$IWM: Downtrend
$BTC: Downtrend
$SQQQ: No trend
$UVIX: No trend
$TLT: Downtrend
$USO: Downtrend
$TNX: Uptrend
$GLD: Downtrend
$SLV: Downtrend
$SLX: Downtrend
2%+ sectors yesterday:
None
2%- sectors yesterday:
$SMH -5.11%
$TAN -3.48%
$XLK -3.24%
$XTL -2.60%
$IGV -2.16%
$IBB -2.13%
Main sectors monthly trailing:
Leading – $XLV $XHP
Lagging – $XLE $XLK
Sub sectors monthly trailing:
Leading – $RTH $JETS
Lagging – $IGV $SMH
Bitcoin: 65k ish
Current market themes:
Theme 1: Big Pharma & GLP-1 Defensive Leadership
Catalyst: Investors are moving money out of AI and into steady earners. Lilly’s Q3 sales hit $24.4 billion, about $1.9 billion above forecasts, and AbbVie, Lilly and Gilead are trading at or near record highs.
Sectors: Big pharma, obesity drugs (GLP-1), large-cap biotech, medtech.
Conviction: High. Strong earnings plus a defensive bid while a rate hike is coming.
Ticker
Company
Sector/Industry
Last (13 Nov)
1D %
Market Cap
YTD
Key Catalyst
Analyst Consensus
LLY
Eli Lilly and Company
Pharma / GLP-1
1443.50
1.26
~$1.3T (verify)
verify
Raised 2026 guidance; record highs
verify
ABBV
AbbVie Inc.
Pharma
295.03
0.20
verify
>25%
52-week highs after Q3
verify
JNJ
Johnson & Johnson
Pharma / Medtech
285.75
0.79
verify
verify
Defensive rotation
verify
MRK
Merck & Co., Inc.
Pharma
147.76
0.55
verify
verify
Q3 beat
verify
AMGN
Amgen Inc.
Biotech / Obesity
465.67
-0.30
verify
verify
Obesity pipeline
verify
GILD
Gilead Sciences, Inc.
Biotech
168.08
0.08
verify
verify
Near record highs
verify
AZN
AstraZeneca PLC (ADR)
Pharma
184.45
0.04
verify
verify
Defensive bid
verify
NVO
Novo Nordisk A/S (ADR)
Pharma / GLP-1
41.63
2.41
verify
verify
GLP-1 laggard catch-up
verify
BMY
Bristol-Myers Squibb Company
Pharma
63.43
1.78
verify
verify
Value rotation
verify
PFE
Pfizer Inc.
Pharma
28.89
0.21
verify
verify
Low-valuation defensive
verify
REGN
Regeneron Pharmaceuticals, Inc.
Biotech
955.47
0.45
verify
verify
Pipeline momentum
verify
VRTX
Vertex Pharmaceuticals Incorporated
Biotech
538.60
-0.74
verify
verify
Defensive growth
verify
ISRG
Intuitive Surgical, Inc.
Medtech / Robotics
443.59
0.84
verify
verify
Procedure growth
verify
BSX
Boston Scientific Corporation
Medtech
44.34
0.32
verify
verify
Medtech rotation
verify
VKTX
Viking Therapeutics, Inc.
Biotech / Obesity
29.22
5.95
verify
verify
Oral VK2735 heading to phase III in Q4 2026
verify
ETFs
XLV (188.85), IHE, IBB, XBI
Theme 2: Energy & the Hormuz Risk Premium
Catalyst: Energy is 2026’s best-performing sector, and it was one of the groups investors moved into on Friday. The risk is the oil price: Brent traded above $112 at the start of November, and the slide came on growing hopes for a US-Iran peace deal. Brent is now near $96 and WTI near $88.
Conviction: Medium. It’s an inflation hedge and still a geopolitical hedge, but it depends on what oil does next.
Ticker
Company
Sector/Industry
Last (13 Nov)
1D %
Market Cap
YTD
Key Catalyst
Analyst Consensus
XOM
Exxon Mobil Corporation
Integrated Oil
170.59
0.48
verify
verify
Hormuz headlines; Q3 beat
verify
CVX
Chevron Corporation
Integrated Oil
219.89
1.64
verify
verify
Oil price sensitivity
verify
COP
ConocoPhillips
Oil Producer
142.28
1.59
verify
verify
Crude rebound
verify
EOG
EOG Resources, Inc.
Oil Producer
158.32
1.74
verify
verify
Went into 2026 completely unhedged
verify
OXY
Occidental Petroleum Corporation
Oil Producer
58.75
0.60
verify
verify
Adjusted EPS of $1.91
verify
DVN
Devon Energy Corporation
Oil Producer
46.58
0.76
verify
verify
Crude beta
verify
FANG
Diamondback Energy, Inc.
Oil Producer
184.93
1.50
verify
verify
Permian producer
verify
SLB
SLB N.V.
Oilfield Services
51.63
1.41
verify
verify
International spending
verify
HAL
Halliburton Company
Oilfield Services
33.50
2.26
verify
verify
Oilfield services recovery
verify
BKR
Baker Hughes Company
Oilfield Services / LNG Equipment
49.44
1.19
verify
verify
LNG and power equipment
verify
VLO
Valero Energy Corporation
Refining
379.83
1.30
verify
verify
Refining margins
verify
MPC
Marathon Petroleum Corporation
Refining
414.65
0.44
verify
verify
Refining margins
verify
PSX
Phillips 66
Refining / Midstream
265.98
1.17
verify
verify
Refining plus midstream
verify
LNG
Cheniere Energy, Inc.
LNG Export
308.75
-0.24
verify
verify
Global LNG demand
verify
KGS
Kodiak Gas Services, Inc.
Gas Compression
45.16
1.71
verify
verify
Jumped on a record quarter
verify
ETFs
XLE (64.96), XOP, OIH, VDE
What type of market are we in: Choppy, Tech remains weak
Key things for this week: This week is all about Nvidia on Tuesday evening, and it’s an unusual setup. It’s the company’s first report since Jensen Huang resigned as CEO on 12 November, with CFO Colette Kress now interim CEO. The stock had already fallen 29.4% in five weeks with no new results, and its P/E is the lowest since 2019. Nvidia guided to revenue of $108.0bn (plus or minus 2%), almost double the same quarter a year earlier. At the 12 November close it was worth about $4.01 trillion, more than the other 83 companies reporting that week combined, so its numbers and guidance will set the tone for the whole AI and semis complex. Around it, the week is a holiday-shopping test: Home Depot and Disney report Tuesday morning, Target, Lowe’s and TJX on Wednesday morning, and Walmart on Thursday morning. Tariff refunds are a common theme across the retailers. On the macro side, October retail sales land on Tuesday morning and the Fed’s October meeting minutes on Wednesday afternoon. UK CPI is also due this week.
Are breakouts working: No
Are breakouts likely to work for the next 3 – 5 days: No, 20% study bullish down to 12 so in the bounce area, $NVDA tonight and Anthropic IPO expected to start trading Thurs which might be pulling a lot of liquidity out of the market.
Are breakdowns likely to work for the next 3 – 5 days: No, not a low risk area with today being day 4 of the down move.
Should I be trading: Quick 5m ROE’s
Todays watchlist (stocks setting up): Nothing at the moment
Fridays market: Money leaving the market – High selling pressure
TC2000 McClellan: 6
Stocks above 40PMA T2108: 47
VIX: 19
52 week highs (US common stocks): 279
Seasonality:
The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.
The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.
The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.
Indices:
$SOXX No trend
$QQQ: No trend
$SPY: No trend
$RSP: Uptrend
$DIA: No trend
$IWM: Downtrend
$BTC: Downtrend
$SQQQ: No trend
$UVIX: Downtrend
$TLT: Downtrend
$USO: Downtrend
$TNX: Uptrend
$GLD: Downtrend
$SLV: Downtrend
$SLX: Downtrend
2%+ sectors Friday:
None
2%- sectors Friday:
$SMH -2.99%
$XLK -2.01%
Main sectors monthly trailing:
Leading – $XLV $XHB
Lagging – $XLE $XLK
Sub sectors monthly trailing:
Leading – $RTH $JETS
Lagging – $IGV $SMH
Bitcoin: 64k ish
Current market themes:
Theme 1: Big Pharma & GLP-1 Defensive Leadership
Catalyst: Investors are moving money out of AI and into steady earners. Lilly’s Q3 sales hit $24.4 billion, about $1.9 billion above forecasts, and AbbVie, Lilly and Gilead are trading at or near record highs.
Sectors: Big pharma, obesity drugs (GLP-1), large-cap biotech, medtech.
Conviction: High. Strong earnings plus a defensive bid while a rate hike is coming.
Ticker
Company
Sector/Industry
Last (13 Nov)
1D %
Market Cap
YTD
Key Catalyst
Analyst Consensus
LLY
Eli Lilly and Company
Pharma / GLP-1
1443.50
1.26
~$1.3T (verify)
verify
Raised 2026 guidance; record highs
verify
ABBV
AbbVie Inc.
Pharma
295.03
0.20
verify
>25%
52-week highs after Q3
verify
JNJ
Johnson & Johnson
Pharma / Medtech
285.75
0.79
verify
verify
Defensive rotation
verify
MRK
Merck & Co., Inc.
Pharma
147.76
0.55
verify
verify
Q3 beat
verify
AMGN
Amgen Inc.
Biotech / Obesity
465.67
-0.30
verify
verify
Obesity pipeline
verify
GILD
Gilead Sciences, Inc.
Biotech
168.08
0.08
verify
verify
Near record highs
verify
AZN
AstraZeneca PLC (ADR)
Pharma
184.45
0.04
verify
verify
Defensive bid
verify
NVO
Novo Nordisk A/S (ADR)
Pharma / GLP-1
41.63
2.41
verify
verify
GLP-1 laggard catch-up
verify
BMY
Bristol-Myers Squibb Company
Pharma
63.43
1.78
verify
verify
Value rotation
verify
PFE
Pfizer Inc.
Pharma
28.89
0.21
verify
verify
Low-valuation defensive
verify
REGN
Regeneron Pharmaceuticals, Inc.
Biotech
955.47
0.45
verify
verify
Pipeline momentum
verify
VRTX
Vertex Pharmaceuticals Incorporated
Biotech
538.60
-0.74
verify
verify
Defensive growth
verify
ISRG
Intuitive Surgical, Inc.
Medtech / Robotics
443.59
0.84
verify
verify
Procedure growth
verify
BSX
Boston Scientific Corporation
Medtech
44.34
0.32
verify
verify
Medtech rotation
verify
VKTX
Viking Therapeutics, Inc.
Biotech / Obesity
29.22
5.95
verify
verify
Oral VK2735 heading to phase III in Q4 2026
verify
ETFs
XLV (188.85), IHE, IBB, XBI
Theme 2: Energy & the Hormuz Risk Premium
Catalyst: Energy is 2026’s best-performing sector, and it was one of the groups investors moved into on Friday. The risk is the oil price: Brent traded above $112 at the start of November, and the slide came on growing hopes for a US-Iran peace deal. Brent is now near $96 and WTI near $88.
Conviction: Medium. It’s an inflation hedge and still a geopolitical hedge, but it depends on what oil does next.
Ticker
Company
Sector/Industry
Last (13 Nov)
1D %
Market Cap
YTD
Key Catalyst
Analyst Consensus
XOM
Exxon Mobil Corporation
Integrated Oil
170.59
0.48
verify
verify
Hormuz headlines; Q3 beat
verify
CVX
Chevron Corporation
Integrated Oil
219.89
1.64
verify
verify
Oil price sensitivity
verify
COP
ConocoPhillips
Oil Producer
142.28
1.59
verify
verify
Crude rebound
verify
EOG
EOG Resources, Inc.
Oil Producer
158.32
1.74
verify
verify
Went into 2026 completely unhedged
verify
OXY
Occidental Petroleum Corporation
Oil Producer
58.75
0.60
verify
verify
Adjusted EPS of $1.91
verify
DVN
Devon Energy Corporation
Oil Producer
46.58
0.76
verify
verify
Crude beta
verify
FANG
Diamondback Energy, Inc.
Oil Producer
184.93
1.50
verify
verify
Permian producer
verify
SLB
SLB N.V.
Oilfield Services
51.63
1.41
verify
verify
International spending
verify
HAL
Halliburton Company
Oilfield Services
33.50
2.26
verify
verify
Oilfield services recovery
verify
BKR
Baker Hughes Company
Oilfield Services / LNG Equipment
49.44
1.19
verify
verify
LNG and power equipment
verify
VLO
Valero Energy Corporation
Refining
379.83
1.30
verify
verify
Refining margins
verify
MPC
Marathon Petroleum Corporation
Refining
414.65
0.44
verify
verify
Refining margins
verify
PSX
Phillips 66
Refining / Midstream
265.98
1.17
verify
verify
Refining plus midstream
verify
LNG
Cheniere Energy, Inc.
LNG Export
308.75
-0.24
verify
verify
Global LNG demand
verify
KGS
Kodiak Gas Services, Inc.
Gas Compression
45.16
1.71
verify
verify
Jumped on a record quarter
verify
ETFs
XLE (64.96), XOP, OIH, VDE
What type of market are we in: Choppy, Tech remains weak
Key things for this week: This week is all about Nvidia on Tuesday evening, and it’s an unusual setup. It’s the company’s first report since Jensen Huang resigned as CEO on 12 November, with CFO Colette Kress now interim CEO. The stock had already fallen 29.4% in five weeks with no new results, and its P/E is the lowest since 2019. Nvidia guided to revenue of $108.0bn (plus or minus 2%), almost double the same quarter a year earlier. At the 12 November close it was worth about $4.01 trillion, more than the other 83 companies reporting that week combined, so its numbers and guidance will set the tone for the whole AI and semis complex. Around it, the week is a holiday-shopping test: Home Depot and Disney report Tuesday morning, Target, Lowe’s and TJX on Wednesday morning, and Walmart on Thursday morning. Tariff refunds are a common theme across the retailers. On the macro side, October retail sales land on Tuesday morning and the Fed’s October meeting minutes on Wednesday afternoon. UK CPI is also due this week.
Are breakouts working: No
Are breakouts likely to work for the next 3 – 5 days: No
Are breakdowns likely to work for the next 3 – 5 days: No
Should I be trading: Quick 5m ROE’s
Todays watchlist (stocks setting up): Nothing at the moment
Yesterdays market: Money leaving the market – Very high selling pressure
TC2000 McClellan: -4
Stocks above 40PMA T2108: 47
VIX: 19
52 week highs (US common stocks): 274
Seasonality:
The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.
The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.
The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.
Indices:
$SOXX No trend
$QQQ: No trend
$SPY: No trend
$RSP: Uptrend
$DIA: No trend
$IWM: No trend
$BTC: Downtrend
$SQQQ: No trend
$UVIX: Downtrend
$TLT: Downtrend
$USO: Downtrend
$TNX: No trend
$GLD: Downtrend
$SLV: No trend
$SLX: No trend
2%+ sectors yesterday:
None
2%- sectors yesterday:
$JETS -3.81%
$TAN -3.69%
$IBB -2.16%
Main sectors monthly trailing:
Leading – $XLV $XLP
Lagging – $XLE $XLK
Sub sectors monthly trailing:
Leading – $RTH $JETS
Lagging – $IGV $SMH
Bitcoin: 69k ish
Current market themes:
Theme 1: Blue Wave Clean Energy and Solar Rebound
Catalyst: Investors expect Congress to stop rolling back clean-energy support. First Solar jumped 9.6% and Enphase rose 10.3% on 4 Nov. Analysts said the result potentially reduces the risk of further political interference with renewable energy incentives, and renewables are also benefiting from a rotation away from AI-related stocks.
Sectors: Solar manufacturing, trackers and inverters, residential solar, storage, renewable power producers and yieldcos
Conviction: Medium. The catalyst is real, but Trump would retain the power to veto legislation, limiting how dramatically federal policy could change.
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
FSLR
First Solar, Inc.
Tech / Solar modules
$18.75B
-22% (Sep)
US manufacturing and 45X credits; $500M buyback
Buy (est.); Mizuho PT $328
NXT
Nextpower Inc.
Tech / Solar trackers
$11.99B
n/a
Utility-scale demand; largest TAN weight
Buy (est.)
ENPH
Enphase Energy, Inc.
Tech / Microinverters
$4.26B
+13% (Sep)
Blue-wave policy relief; residential recovery
Hold (est.)
SEDG
SolarEdge Technologies, Inc.
Tech / Inverters
$1.99B
+19% (Sep)
Up as much as 12% after the election
Hold (est.)
RUN
Sunrun Inc.
Industrials / Residential solar
$1.82B
n/a
Residential credit outlook
Hold/Buy (est.)
SHLS
Shoals Technologies Group, Inc.
Tech / eBOS
$1.26B
n/a
Utility-scale buildout
Hold (est.)
ARRY
Array Technologies, Inc.
Tech / Solar trackers
$513M
n/a
Tracker orderbook
Hold (est.)
CSIQ
Canadian Solar Inc.
Tech / Modules and storage
$663M
n/a
Up 7%+ after the election
Hold (est.)
TE
T1 Energy Inc.
Tech / US module manufacturing
n/a
n/a
Up 11% after the election
Buy (est.)
NEE
NextEra Energy, Inc.
Utilities / Renewables
n/a
n/a
Named among election winners; benefits from lower yields
Buy (est.)
CWEN
Clearway Energy, Inc.
Utilities / Renewable yieldco
n/a
n/a
Contracted renewables; benefits from lower rates
Buy (est.)
HASI
HA Sustainable Infrastructure Capital
Financials / Climate finance
n/a
n/a
Clean-energy financing pipeline
Buy (est.)
BEP
Brookfield Renewable Partners
Utilities / Renewables
n/a
n/a
Global renewables rally
Buy (est.)
FLNC
Fluence Energy, Inc.
Industrials / Battery storage
n/a
n/a
Storage incentives
Hold (est.)
AES
The AES Corporation
Utilities / Renewables developer
n/a
n/a
Renewables pipeline
Hold (est.)
ETFs
TAN, ICLN, PBW, QCLN
Theme 2: Medicaid and ACA Healthcare Services (Hospitals and Managed Care)
Catalyst: The election raised hopes for healthcare-friendly policy. Centene climbed over 8% and Molina about 6%, while HCA, Tenet and Universal Health Services gained between 6% and 8%. Analysts also said the outcome could improve the prospects for extending enhanced ACA subsidies.
Sectors: Hospital operators, Medicaid and ACA managed care, behavioural health, surgical centres
Conviction: High to Medium. This is the clearest policy beneficiary, and healthcare was flat for the week despite the selloff. The risk is that Medicaid relief doesn’t materialize or is replaced by tougher hospital reimbursement rules.
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
HCA
HCA Healthcare, Inc.
Healthcare / Hospitals
$101.6B
~+6% (pre-election)
Up 8.6% after the election; Medicaid exposure
Buy (est.)
THC
Tenet Healthcare Corporation
Healthcare / Hospitals
$21.6B
~+41% (pre-election)
ACA subsidy extension
Buy (est.)
UHS
Universal Health Services, Inc.
Healthcare / Hospitals and behavioural
$11.0B
~-13% (pre-election)
Laggard catch-up; state-directed payments
Buy (est.)
ARDT
Ardent Health, Inc.
Healthcare / Hospitals
$1.73B
n/a
Hospital rerating
Buy (est.)
ACHC
Acadia Healthcare Company
Healthcare / Behavioural health
$2.93B
n/a
Medicaid-heavy revenue mix
Hold (est.)
SGRY
Surgery Partners, Inc.
Healthcare / Surgical centres
$2.04B
n/a
Volume recovery
Buy (est.)
CNC
Centene Corporation
Healthcare / Medicaid MCO
$34.7B
+66% (30 Oct)
Largest Medicaid and ACA insurer
Hold (est.)
MOH
Molina Healthcare, Inc.
Healthcare / Medicaid MCO
$10.9B
n/a
Most exposed to swing-state Medicaid members
Hold (est.)
ELV
Elevance Health, Inc.
Healthcare / Managed care
$95.1B
~+21%
Medicaid margins past the trough
Buy (est.)
OSCR
Oscar Health, Inc.
Healthcare / ACA insurer
$9.56B
n/a
Most direct ACA-subsidy play
Hold (est.)
UNH
UnitedHealth Group
Healthcare / Managed care
$375.3B
~+30%
Sector leader; Medicare Advantage rates
Buy (est.)
HUM
Humana Inc.
Healthcare / Medicare Advantage
$50.7B
n/a
Medicare Advantage rate tailwind
Hold (est.)
CVS
CVS Health Corporation
Healthcare / Insurance and pharmacy
$119.6B
n/a
Aetna margin recovery
Buy (est.)
CI
The Cigna Group
Healthcare / Managed care
$81.1B
n/a
Lower Medicaid exposure (defensive)
Buy (est.)
ALHC
Alignment Healthcare, Inc.
Healthcare / Medicare Advantage
$1.67B
n/a
Medicare Advantage growth
Buy (est.)
ETFs
IHF, XLV
What type of market are we in: Choppy, Tech remains weak
Key things for this week: This is a quieter earnings week, but a fragile one after last Thursday’s AI and chip sell-off, and the key event is Tuesday’s October CPI at 13:30 UK. It will show no year-on-year rate because of the 2025 shutdown, so markets will trade the month-on-month figure (consensus around 0.2–0.3%). It’s the last CPI before the Fed’s 9 December meeting, where futures had priced roughly a 65% chance of a hike. On earnings, Monday brings KKR and Barrick in the morning, then Take-Two (ten days before GTA VI), Skydance, Occidental, Rocket Lab and The Trade Desk after the close. Tuesday has Vodafone, Sea Limited and TransDigm before the open, then CoreWeave in the evening as the first AI-sentiment test. Wednesday is Veterans Day: stocks are open, bonds are shut, and volume will be light. Thursday brings UK Q3 GDP and Nebius in the morning, then the week’s headline reports, Cisco and Applied Materials, after the US close (calls at 21:30 UK). Friday closes with PPI at 13:30 and the big Japanese banks. Next week’s major event is Nvidia on Tuesday 17 November, alongside Disney and Home Depot.
Are breakouts working: No
Are breakouts likely to work for the next 3 – 5 days: No
Are breakdowns likely to work for the next 3 – 5 days: Maybe, lots of charts setting up bearish, will be very bullish if turn into fake breakdowns
Should I be trading: WSS only
Todays watchlist (stocks setting up): Nothing at the moment
Yesterdays market: Money entering the market – High buying pressure
TC2000 McClellan: 49
Stocks above 40PMA T2108: 51
VIX: 17
52 week highs (US common stocks): 308
Seasonality:
The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.
The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.
The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.
Indices:
$SOXX No trend
$QQQ: No trend
$SPY: No trend
$RSP: Uptrend
$DIA: No trend
$IWM: Uptrend
$BTC: Downtrend
$SQQQ: No trend
$UVIX: Downtrend
$TLT: Downtrend
$USO: Downtrend
$TNX: No trend
$GLD: No trend
$SLV: No trend
$SLX: No trend
2%+ sectors yesterday:
$SMH +4.82%
$XLK +3.23%
$XTL +2.35%
2%- sectors yesterday:
None
Main sectors monthly trailing:
Leading – $XLV $XHB
Lagging – $XLE $XLK
Sub sectors monthly trailing:
Leading – $RTH $JETS
Lagging – $IGV $SMH
Bitcoin: 74k ish
Current market themes:
Theme 1: Blue Wave Clean Energy and Solar Rebound
Catalyst: Investors expect Congress to stop rolling back clean-energy support. First Solar jumped 9.6% and Enphase rose 10.3% on 4 Nov. Analysts said the result potentially reduces the risk of further political interference with renewable energy incentives, and renewables are also benefiting from a rotation away from AI-related stocks.
Sectors: Solar manufacturing, trackers and inverters, residential solar, storage, renewable power producers and yieldcos
Conviction: Medium. The catalyst is real, but Trump would retain the power to veto legislation, limiting how dramatically federal policy could change.
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
FSLR
First Solar, Inc.
Tech / Solar modules
$18.75B
-22% (Sep)
US manufacturing and 45X credits; $500M buyback
Buy (est.); Mizuho PT $328
NXT
Nextpower Inc.
Tech / Solar trackers
$11.99B
n/a
Utility-scale demand; largest TAN weight
Buy (est.)
ENPH
Enphase Energy, Inc.
Tech / Microinverters
$4.26B
+13% (Sep)
Blue-wave policy relief; residential recovery
Hold (est.)
SEDG
SolarEdge Technologies, Inc.
Tech / Inverters
$1.99B
+19% (Sep)
Up as much as 12% after the election
Hold (est.)
RUN
Sunrun Inc.
Industrials / Residential solar
$1.82B
n/a
Residential credit outlook
Hold/Buy (est.)
SHLS
Shoals Technologies Group, Inc.
Tech / eBOS
$1.26B
n/a
Utility-scale buildout
Hold (est.)
ARRY
Array Technologies, Inc.
Tech / Solar trackers
$513M
n/a
Tracker orderbook
Hold (est.)
CSIQ
Canadian Solar Inc.
Tech / Modules and storage
$663M
n/a
Up 7%+ after the election
Hold (est.)
TE
T1 Energy Inc.
Tech / US module manufacturing
n/a
n/a
Up 11% after the election
Buy (est.)
NEE
NextEra Energy, Inc.
Utilities / Renewables
n/a
n/a
Named among election winners; benefits from lower yields
Buy (est.)
CWEN
Clearway Energy, Inc.
Utilities / Renewable yieldco
n/a
n/a
Contracted renewables; benefits from lower rates
Buy (est.)
HASI
HA Sustainable Infrastructure Capital
Financials / Climate finance
n/a
n/a
Clean-energy financing pipeline
Buy (est.)
BEP
Brookfield Renewable Partners
Utilities / Renewables
n/a
n/a
Global renewables rally
Buy (est.)
FLNC
Fluence Energy, Inc.
Industrials / Battery storage
n/a
n/a
Storage incentives
Hold (est.)
AES
The AES Corporation
Utilities / Renewables developer
n/a
n/a
Renewables pipeline
Hold (est.)
ETFs
TAN, ICLN, PBW, QCLN
Theme 2: Medicaid and ACA Healthcare Services (Hospitals and Managed Care)
Catalyst: The election raised hopes for healthcare-friendly policy. Centene climbed over 8% and Molina about 6%, while HCA, Tenet and Universal Health Services gained between 6% and 8%. Analysts also said the outcome could improve the prospects for extending enhanced ACA subsidies.
Sectors: Hospital operators, Medicaid and ACA managed care, behavioural health, surgical centres
Conviction: High to Medium. This is the clearest policy beneficiary, and healthcare was flat for the week despite the selloff. The risk is that Medicaid relief doesn’t materialize or is replaced by tougher hospital reimbursement rules.
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
HCA
HCA Healthcare, Inc.
Healthcare / Hospitals
$101.6B
~+6% (pre-election)
Up 8.6% after the election; Medicaid exposure
Buy (est.)
THC
Tenet Healthcare Corporation
Healthcare / Hospitals
$21.6B
~+41% (pre-election)
ACA subsidy extension
Buy (est.)
UHS
Universal Health Services, Inc.
Healthcare / Hospitals and behavioural
$11.0B
~-13% (pre-election)
Laggard catch-up; state-directed payments
Buy (est.)
ARDT
Ardent Health, Inc.
Healthcare / Hospitals
$1.73B
n/a
Hospital rerating
Buy (est.)
ACHC
Acadia Healthcare Company
Healthcare / Behavioural health
$2.93B
n/a
Medicaid-heavy revenue mix
Hold (est.)
SGRY
Surgery Partners, Inc.
Healthcare / Surgical centres
$2.04B
n/a
Volume recovery
Buy (est.)
CNC
Centene Corporation
Healthcare / Medicaid MCO
$34.7B
+66% (30 Oct)
Largest Medicaid and ACA insurer
Hold (est.)
MOH
Molina Healthcare, Inc.
Healthcare / Medicaid MCO
$10.9B
n/a
Most exposed to swing-state Medicaid members
Hold (est.)
ELV
Elevance Health, Inc.
Healthcare / Managed care
$95.1B
~+21%
Medicaid margins past the trough
Buy (est.)
OSCR
Oscar Health, Inc.
Healthcare / ACA insurer
$9.56B
n/a
Most direct ACA-subsidy play
Hold (est.)
UNH
UnitedHealth Group
Healthcare / Managed care
$375.3B
~+30%
Sector leader; Medicare Advantage rates
Buy (est.)
HUM
Humana Inc.
Healthcare / Medicare Advantage
$50.7B
n/a
Medicare Advantage rate tailwind
Hold (est.)
CVS
CVS Health Corporation
Healthcare / Insurance and pharmacy
$119.6B
n/a
Aetna margin recovery
Buy (est.)
CI
The Cigna Group
Healthcare / Managed care
$81.1B
n/a
Lower Medicaid exposure (defensive)
Buy (est.)
ALHC
Alignment Healthcare, Inc.
Healthcare / Medicare Advantage
$1.67B
n/a
Medicare Advantage growth
Buy (est.)
ETFs
IHF, XLV
What type of market are we in: Choppy, SOXX, QQQ, SPY moved to no trend, today will be day 5 of the move from the lows so expect some kind of pull back before the next move if these are the lows.
Key things for this week: This is a quieter earnings week, but a fragile one after last Thursday’s AI and chip sell-off, and the key event is Tuesday’s October CPI at 13:30 UK. It will show no year-on-year rate because of the 2025 shutdown, so markets will trade the month-on-month figure (consensus around 0.2–0.3%). It’s the last CPI before the Fed’s 9 December meeting, where futures had priced roughly a 65% chance of a hike. On earnings, Monday brings KKR and Barrick in the morning, then Take-Two (ten days before GTA VI), Skydance, Occidental, Rocket Lab and The Trade Desk after the close. Tuesday has Vodafone, Sea Limited and TransDigm before the open, then CoreWeave in the evening as the first AI-sentiment test. Wednesday is Veterans Day: stocks are open, bonds are shut, and volume will be light. Thursday brings UK Q3 GDP and Nebius in the morning, then the week’s headline reports, Cisco and Applied Materials, after the US close (calls at 21:30 UK). Friday closes with PPI at 13:30 and the big Japanese banks. Next week’s major event is Nvidia on Tuesday 17 November, alongside Disney and Home Depot.
Are breakouts working: Selectively
Are breakouts likely to work for the next 3 – 5 days: No, entering day 5 of the move, stocks tend to move in 3 – 5 day bursts.
Are breakdowns likely to work for the next 3 – 5 days: Maybe, lots of charts setting up bearish, will be very bullish if turn into fake breakdowns
Should I be trading: RR no there after 4 up days, only EPs.
Todays watchlist (stocks setting up): Nothing at the moment
Yesterdays market: Money leaving the market – High selling pressure
TC2000 McClellan: 42
Stocks above 40PMA T2108: 50
VIX: 19
52 week highs (US common stocks): 311
Seasonality:
The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.
The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.
The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.
Indices:
$SOXX Downtrend
$QQQ: Downtrend
$SPY: Downtrend
$RSP: Uptrend
$DIA: No trend
$IWM: Uptrend
$BTC: Downtrend
$SQQQ: Uptrend
$UVIX: No trend
$TLT: No trend
$USO: Downtrend
$TNX: No trend
$GLD: No trend
$SLV: No trend
$SLX: No trend
2%+ sectors yesterday:
None
2%- sectors yesterday:
$TAN -3.70%
$XHB -2.63%
Main sectors monthly trailing:
Leading – $XLV $XLP
Lagging – $XLE $XLK
Sub sectors monthly trailing:
Leading – $RTH $JETS
Lagging – $HACK $SMH
Bitcoin: 74k ish
Current market themes:
Theme 1: Blue Wave Clean Energy and Solar Rebound
Catalyst: Investors expect Congress to stop rolling back clean-energy support. First Solar jumped 9.6% and Enphase rose 10.3% on 4 Nov. Analysts said the result potentially reduces the risk of further political interference with renewable energy incentives, and renewables are also benefiting from a rotation away from AI-related stocks.
Sectors: Solar manufacturing, trackers and inverters, residential solar, storage, renewable power producers and yieldcos
Conviction: Medium. The catalyst is real, but Trump would retain the power to veto legislation, limiting how dramatically federal policy could change.
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
FSLR
First Solar, Inc.
Tech / Solar modules
$18.75B
-22% (Sep)
US manufacturing and 45X credits; $500M buyback
Buy (est.); Mizuho PT $328
NXT
Nextpower Inc.
Tech / Solar trackers
$11.99B
n/a
Utility-scale demand; largest TAN weight
Buy (est.)
ENPH
Enphase Energy, Inc.
Tech / Microinverters
$4.26B
+13% (Sep)
Blue-wave policy relief; residential recovery
Hold (est.)
SEDG
SolarEdge Technologies, Inc.
Tech / Inverters
$1.99B
+19% (Sep)
Up as much as 12% after the election
Hold (est.)
RUN
Sunrun Inc.
Industrials / Residential solar
$1.82B
n/a
Residential credit outlook
Hold/Buy (est.)
SHLS
Shoals Technologies Group, Inc.
Tech / eBOS
$1.26B
n/a
Utility-scale buildout
Hold (est.)
ARRY
Array Technologies, Inc.
Tech / Solar trackers
$513M
n/a
Tracker orderbook
Hold (est.)
CSIQ
Canadian Solar Inc.
Tech / Modules and storage
$663M
n/a
Up 7%+ after the election
Hold (est.)
TE
T1 Energy Inc.
Tech / US module manufacturing
n/a
n/a
Up 11% after the election
Buy (est.)
NEE
NextEra Energy, Inc.
Utilities / Renewables
n/a
n/a
Named among election winners; benefits from lower yields
Buy (est.)
CWEN
Clearway Energy, Inc.
Utilities / Renewable yieldco
n/a
n/a
Contracted renewables; benefits from lower rates
Buy (est.)
HASI
HA Sustainable Infrastructure Capital
Financials / Climate finance
n/a
n/a
Clean-energy financing pipeline
Buy (est.)
BEP
Brookfield Renewable Partners
Utilities / Renewables
n/a
n/a
Global renewables rally
Buy (est.)
FLNC
Fluence Energy, Inc.
Industrials / Battery storage
n/a
n/a
Storage incentives
Hold (est.)
AES
The AES Corporation
Utilities / Renewables developer
n/a
n/a
Renewables pipeline
Hold (est.)
ETFs
TAN, ICLN, PBW, QCLN
Theme 2: Medicaid and ACA Healthcare Services (Hospitals and Managed Care)
Catalyst: The election raised hopes for healthcare-friendly policy. Centene climbed over 8% and Molina about 6%, while HCA, Tenet and Universal Health Services gained between 6% and 8%. Analysts also said the outcome could improve the prospects for extending enhanced ACA subsidies.
Sectors: Hospital operators, Medicaid and ACA managed care, behavioural health, surgical centres
Conviction: High to Medium. This is the clearest policy beneficiary, and healthcare was flat for the week despite the selloff. The risk is that Medicaid relief doesn’t materialize or is replaced by tougher hospital reimbursement rules.
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
HCA
HCA Healthcare, Inc.
Healthcare / Hospitals
$101.6B
~+6% (pre-election)
Up 8.6% after the election; Medicaid exposure
Buy (est.)
THC
Tenet Healthcare Corporation
Healthcare / Hospitals
$21.6B
~+41% (pre-election)
ACA subsidy extension
Buy (est.)
UHS
Universal Health Services, Inc.
Healthcare / Hospitals and behavioural
$11.0B
~-13% (pre-election)
Laggard catch-up; state-directed payments
Buy (est.)
ARDT
Ardent Health, Inc.
Healthcare / Hospitals
$1.73B
n/a
Hospital rerating
Buy (est.)
ACHC
Acadia Healthcare Company
Healthcare / Behavioural health
$2.93B
n/a
Medicaid-heavy revenue mix
Hold (est.)
SGRY
Surgery Partners, Inc.
Healthcare / Surgical centres
$2.04B
n/a
Volume recovery
Buy (est.)
CNC
Centene Corporation
Healthcare / Medicaid MCO
$34.7B
+66% (30 Oct)
Largest Medicaid and ACA insurer
Hold (est.)
MOH
Molina Healthcare, Inc.
Healthcare / Medicaid MCO
$10.9B
n/a
Most exposed to swing-state Medicaid members
Hold (est.)
ELV
Elevance Health, Inc.
Healthcare / Managed care
$95.1B
~+21%
Medicaid margins past the trough
Buy (est.)
OSCR
Oscar Health, Inc.
Healthcare / ACA insurer
$9.56B
n/a
Most direct ACA-subsidy play
Hold (est.)
UNH
UnitedHealth Group
Healthcare / Managed care
$375.3B
~+30%
Sector leader; Medicare Advantage rates
Buy (est.)
HUM
Humana Inc.
Healthcare / Medicare Advantage
$50.7B
n/a
Medicare Advantage rate tailwind
Hold (est.)
CVS
CVS Health Corporation
Healthcare / Insurance and pharmacy
$119.6B
n/a
Aetna margin recovery
Buy (est.)
CI
The Cigna Group
Healthcare / Managed care
$81.1B
n/a
Lower Medicaid exposure (defensive)
Buy (est.)
ALHC
Alignment Healthcare, Inc.
Healthcare / Medicare Advantage
$1.67B
n/a
Medicare Advantage growth
Buy (est.)
ETFs
IHF, XLV
What type of market are we in: Bearish, SOXX, QQQ, SPY in downtrends
Key things for this week: This is a quieter earnings week, but a fragile one after last Thursday’s AI and chip sell-off, and the key event is Tuesday’s October CPI at 13:30 UK. It will show no year-on-year rate because of the 2025 shutdown, so markets will trade the month-on-month figure (consensus around 0.2–0.3%). It’s the last CPI before the Fed’s 9 December meeting, where futures had priced roughly a 65% chance of a hike. On earnings, Monday brings KKR and Barrick in the morning, then Take-Two (ten days before GTA VI), Skydance, Occidental, Rocket Lab and The Trade Desk after the close. Tuesday has Vodafone, Sea Limited and TransDigm before the open, then CoreWeave in the evening as the first AI-sentiment test. Wednesday is Veterans Day: stocks are open, bonds are shut, and volume will be light. Thursday brings UK Q3 GDP and Nebius in the morning, then the week’s headline reports, Cisco and Applied Materials, after the US close (calls at 21:30 UK). Friday closes with PPI at 13:30 and the big Japanese banks. Next week’s major event is Nvidia on Tuesday 17 November, alongside Disney and Home Depot.
Are breakouts working: No, 20% bullish also elevated over 100
Are breakouts likely to work for the next 3 – 5 days: No
Are breakdowns likely to work for the next 3 – 5 days: Maybe, lots of charts setting up bearish, will be very bullish if turn into fake breakdowns
Should I be trading: Only short term 5 ROE for my style of trading
Todays watchlist (stocks setting up): $HPE $TRMB weak structure short
Fridays market: Money entering the market – Normal buying pressure
TC2000 McClellan: 4
Stocks above 40PMA T2108: 44
VIX: 26
52 week highs (US common stocks): 233
Seasonality:
The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.
The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.
The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.
Indices:
$SOXX Downtrend
$QQQ: Downtrend
$SPY: Downtrend
$RSP: Downtrend
$DIA: Downtrend
$IWM: Downtrend
$BTC: Downtrend
$SQQQ: Uptrend
$UVIX: Uptrend
$TLT: Uptrend
$USO: Downtrend
$TNX: Downtrend
$GLD: Uptrend
$SLV: Downtrend
$SLX: Downtrend
2%+ sectors Friday:
$SMH +3.62%
$XTL +3.44%
$TAN +3.38%
2%- sectors Friday:
None
Main sectors monthly trailing:
Leading – $XLV $XLP
Lagging – $XLI $XLK
Sub sectors monthly trailing:
Leading – $RTH $TLT
Lagging – $HACK $SMH
Bitcoin: 74k ish
Current market themes:
Theme 1: Blue Wave Clean Energy and Solar Rebound
Catalyst: Investors expect Congress to stop rolling back clean-energy support. First Solar jumped 9.6% and Enphase rose 10.3% on 4 Nov. Analysts said the result potentially reduces the risk of further political interference with renewable energy incentives, and renewables are also benefiting from a rotation away from AI-related stocks.
Sectors: Solar manufacturing, trackers and inverters, residential solar, storage, renewable power producers and yieldcos
Conviction: Medium. The catalyst is real, but Trump would retain the power to veto legislation, limiting how dramatically federal policy could change.
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
FSLR
First Solar, Inc.
Tech / Solar modules
$18.75B
-22% (Sep)
US manufacturing and 45X credits; $500M buyback
Buy (est.); Mizuho PT $328
NXT
Nextpower Inc.
Tech / Solar trackers
$11.99B
n/a
Utility-scale demand; largest TAN weight
Buy (est.)
ENPH
Enphase Energy, Inc.
Tech / Microinverters
$4.26B
+13% (Sep)
Blue-wave policy relief; residential recovery
Hold (est.)
SEDG
SolarEdge Technologies, Inc.
Tech / Inverters
$1.99B
+19% (Sep)
Up as much as 12% after the election
Hold (est.)
RUN
Sunrun Inc.
Industrials / Residential solar
$1.82B
n/a
Residential credit outlook
Hold/Buy (est.)
SHLS
Shoals Technologies Group, Inc.
Tech / eBOS
$1.26B
n/a
Utility-scale buildout
Hold (est.)
ARRY
Array Technologies, Inc.
Tech / Solar trackers
$513M
n/a
Tracker orderbook
Hold (est.)
CSIQ
Canadian Solar Inc.
Tech / Modules and storage
$663M
n/a
Up 7%+ after the election
Hold (est.)
TE
T1 Energy Inc.
Tech / US module manufacturing
n/a
n/a
Up 11% after the election
Buy (est.)
NEE
NextEra Energy, Inc.
Utilities / Renewables
n/a
n/a
Named among election winners; benefits from lower yields
Buy (est.)
CWEN
Clearway Energy, Inc.
Utilities / Renewable yieldco
n/a
n/a
Contracted renewables; benefits from lower rates
Buy (est.)
HASI
HA Sustainable Infrastructure Capital
Financials / Climate finance
n/a
n/a
Clean-energy financing pipeline
Buy (est.)
BEP
Brookfield Renewable Partners
Utilities / Renewables
n/a
n/a
Global renewables rally
Buy (est.)
FLNC
Fluence Energy, Inc.
Industrials / Battery storage
n/a
n/a
Storage incentives
Hold (est.)
AES
The AES Corporation
Utilities / Renewables developer
n/a
n/a
Renewables pipeline
Hold (est.)
ETFs
TAN, ICLN, PBW, QCLN
Theme 2: Medicaid and ACA Healthcare Services (Hospitals and Managed Care)
Catalyst: The election raised hopes for healthcare-friendly policy. Centene climbed over 8% and Molina about 6%, while HCA, Tenet and Universal Health Services gained between 6% and 8%. Analysts also said the outcome could improve the prospects for extending enhanced ACA subsidies.
Sectors: Hospital operators, Medicaid and ACA managed care, behavioural health, surgical centres
Conviction: High to Medium. This is the clearest policy beneficiary, and healthcare was flat for the week despite the selloff. The risk is that Medicaid relief doesn’t materialize or is replaced by tougher hospital reimbursement rules.
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
HCA
HCA Healthcare, Inc.
Healthcare / Hospitals
$101.6B
~+6% (pre-election)
Up 8.6% after the election; Medicaid exposure
Buy (est.)
THC
Tenet Healthcare Corporation
Healthcare / Hospitals
$21.6B
~+41% (pre-election)
ACA subsidy extension
Buy (est.)
UHS
Universal Health Services, Inc.
Healthcare / Hospitals and behavioural
$11.0B
~-13% (pre-election)
Laggard catch-up; state-directed payments
Buy (est.)
ARDT
Ardent Health, Inc.
Healthcare / Hospitals
$1.73B
n/a
Hospital rerating
Buy (est.)
ACHC
Acadia Healthcare Company
Healthcare / Behavioural health
$2.93B
n/a
Medicaid-heavy revenue mix
Hold (est.)
SGRY
Surgery Partners, Inc.
Healthcare / Surgical centres
$2.04B
n/a
Volume recovery
Buy (est.)
CNC
Centene Corporation
Healthcare / Medicaid MCO
$34.7B
+66% (30 Oct)
Largest Medicaid and ACA insurer
Hold (est.)
MOH
Molina Healthcare, Inc.
Healthcare / Medicaid MCO
$10.9B
n/a
Most exposed to swing-state Medicaid members
Hold (est.)
ELV
Elevance Health, Inc.
Healthcare / Managed care
$95.1B
~+21%
Medicaid margins past the trough
Buy (est.)
OSCR
Oscar Health, Inc.
Healthcare / ACA insurer
$9.56B
n/a
Most direct ACA-subsidy play
Hold (est.)
UNH
UnitedHealth Group
Healthcare / Managed care
$375.3B
~+30%
Sector leader; Medicare Advantage rates
Buy (est.)
HUM
Humana Inc.
Healthcare / Medicare Advantage
$50.7B
n/a
Medicare Advantage rate tailwind
Hold (est.)
CVS
CVS Health Corporation
Healthcare / Insurance and pharmacy
$119.6B
n/a
Aetna margin recovery
Buy (est.)
CI
The Cigna Group
Healthcare / Managed care
$81.1B
n/a
Lower Medicaid exposure (defensive)
Buy (est.)
ALHC
Alignment Healthcare, Inc.
Healthcare / Medicare Advantage
$1.67B
n/a
Medicare Advantage growth
Buy (est.)
ETFs
IHF, XLV
What type of market are we in: Bearish, all indices in downtrends. Markets need to reset and charts setup.
Key things for this week: This is a quieter earnings week, but a fragile one after last Thursday’s AI and chip sell-off, and the key event is Tuesday’s October CPI at 13:30 UK. It will show no year-on-year rate because of the 2025 shutdown, so markets will trade the month-on-month figure (consensus around 0.2–0.3%). It’s the last CPI before the Fed’s 9 December meeting, where futures had priced roughly a 65% chance of a hike. On earnings, Monday brings KKR and Barrick in the morning, then Take-Two (ten days before GTA VI), Skydance, Occidental, Rocket Lab and The Trade Desk after the close. Tuesday has Vodafone, Sea Limited and TransDigm before the open, then CoreWeave in the evening as the first AI-sentiment test. Wednesday is Veterans Day: stocks are open, bonds are shut, and volume will be light. Thursday brings UK Q3 GDP and Nebius in the morning, then the week’s headline reports, Cisco and Applied Materials, after the US close (calls at 21:30 UK). Friday closes with PPI at 13:30 and the big Japanese banks. Next week’s major event is Nvidia on Tuesday 17 November, alongside Disney and Home Depot.
Are breakouts working: No
Are breakouts likely to work for the next 3 – 5 days: No, all indexes in downtrnds.
Are breakdowns likely to work for the next 3 – 5 days: RR typically not there after big flush 20% bearish study over 100
Should I be trading: Only short term bounce trades using 5m ROE
Todays watchlist (stocks setting up): None at the moment
Yesterdays market: Money leaving the market – Extreme selling pressure
TC2000 McClellan: 9
Stocks above 40PMA T2108: 45
VIX: 28
52 week highs (US common stocks): 240
Seasonality:
The historical case: The post-midterm window is the cycle’s strongest stretch. From the 31 October close of a midterm year to the following 30 April, the S&P 500 has been positive in all 19 cycles since 1950, averaging nearly 15%.
The base rate is strong. Since 1950 the S&P 500 has averaged a 1.7% gain in November, tied with December for the best month according to the Stock Trader’s Almanac. In midterm years the Almanac ranks November as the second best month for the DJIA and S&P 500. November also starts the “Best Six Months”. Small caps come into favour in November but don’t really take off until the last two weeks of the year.
The odds favour a positive month, and November–April has the best risk/reward of the four-year cycle. But 2026 starts closer to the highs than most midterm years. Expect smaller gains than the averages, and leadership may sit outside mega-cap tech. A tech-led drawdown in November is entirely possible and wouldn’t break the pattern. History says weak patches before or around the vote have usually been bought.
Indices:
$SOXX Downtrend
$QQQ: Downtrend
$SPY: No trend
$RSP: No trend
$DIA: No trend
$IWM: No trend
$BTC: Downtrend
$SQQQ: Uptrend
$UVIX: No trend
$TLT: Uptrend
$USO: Downtrend
$TNX: Downtrend
$GLD: No trend
$SLV: Downtrend
$SLX: Downtrend
2%+ sectors yesterday:
None
2%- sectors yesterday:
$SMH -11.21%
$XLK -8.00%
$XTL -7.84%
$HACK -6.88%
$IBB -5.04%
$IGV -4.39%
$XLI -4.12%
$XLY -3.83%
$JETS -3.73%
$TAN -3.71%
$IYT -3.54%
$XHB -3.41%
$XLE -2.98%
$XLB -2.91%
$XLF -2.87%
$XLV -2.50%
$KRE -2.46%
Main sectors monthly trailing:
Leading – $XLV $XLP
Lagging – $XLI $XLK
Sub sectors monthly trailing:
Leading – $RTH $TLT
Lagging – $HACK $SMH
Bitcoin: 76k ish
Themes:
Cybersecurity
Infrastructure
Cloud Computing
Semiconductors
Software
Clean energy
Crypto
Theme 1: Healthcare Leadership, GLP-1 and Big Biopharma Rotation
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
LLY
Eli Lilly and Company
Pharma / Obesity-Diabetes
~$1.2T
~+19%
Q3 beat and raise; retatrutide Ph3 vs Ozempic; Foundayo ramp
Buy; Street PT ~$1,330
REGN
Regeneron Pharmaceuticals, Inc.
Biotech
~$95B
~+19% est.
Q3 beat; +13% on the week
Buy; PT —
ABBV
AbbVie Inc.
Pharma / Immunology
~$400B
—
Q3 reported 30 Oct; Skyrizi/Rinvoq
Buy; PT —
JNJ
Johnson & Johnson
Pharma / Medtech
~$500B
—
Defensive bid; oncology growth
Buy; PT —
MRK
Merck & Co., Inc.
Pharma
~$250B
—
Keytruda subQ transition
Hold/Buy; PT —
AMGN
Amgen Inc.
Biotech / Obesity
~$170B
—
MariTide obesity readouts; Q3 due early Nov
Hold/Buy; PT —
VRTX
Vertex Pharmaceuticals Incorporated
Biotech
~$120B
—
Non-opioid pain and CF franchise
Buy; PT —
GILD
Gilead Sciences, Inc.
Biotech / HIV
~$150B
—
Lenacapavir PrEP launch
Buy; PT —
ALNY
Alnylam Pharmaceuticals, Inc.
Biotech / RNAi
~$60B
—
Amvuttra ATTR-CM growth; joining Nasdaq 100
Buy; PT —
ISRG
Intuitive Surgical, Inc.
Medtech / Robotics
~$190B
—
da Vinci 5 placements
Buy; PT —
BSX
Boston Scientific Corporation
Medtech
~$150B
—
Farapulse electrophysiology growth
Buy; PT —
TMO
Thermo Fisher Scientific Inc.
Life-Science Tools
~$200B
—
Recovery in pharma spending
Buy; PT —
HCA
HCA Healthcare, Inc.
Hospitals
~$100B
—
Volume and policy tailwinds
Buy; PT —
MCK
McKesson Corporation
Drug Distribution
~$90B
—
GLP-1 volumes flowing through distribution
Buy; PT —
CDNA
CareDx, Inc.
Diagnostics / Transplant
~$5B
—
Top gainer last week: +22.22% to 87.41
Buy; PT —
ETFs
XLV · XBI · IBB · VHT · XPH
Theme 2: Hormuz Oil Shock and Refining Super-Margins
Ticker
Company Name
Sector/Industry
Market Cap
YTD Return
Key Catalyst
Analyst Consensus
XOM
Exxon Mobil Corporation
Integrated Oil
~$730B
~+49%
Q3 beat; $20B 2027 buyback
Buy; PT ~$173–175
CVX
Chevron Corporation
Integrated Oil
~$330B
—
Q3 adjusted EPS $5.28; record refinery throughput
Buy; PT —
COP
ConocoPhillips
E&P
~$140B
—
Q3 due early Nov; leveraged to $100 oil
Buy; PT —
EOG
EOG Resources, Inc.
E&P
~$75B
—
Q3 due early Nov
Buy/Hold; PT —
OXY
Occidental Petroleum Corporation
E&P
~$55B
—
Permian volumes; high beta to oil
Hold; PT —
FANG
Diamondback Energy, Inc.
E&P (Permian)
~$50B
—
Capital returns at $100 oil
Buy; PT —
DVN
Devon Energy Corporation
E&P
~$25B
—
Q3 due early Nov
Buy/Hold; PT —
MPC
Marathon Petroleum Corporation
Refining
~$65B
—
Crack spreads at extremes
Buy; PT —
VLO
Valero Energy Corporation
Refining
~$55B
—
Diesel margins
Buy; PT —
PSX
Phillips 66
Refining / Midstream
~$60B
—
Refining plus chemicals
Buy; PT —
PBF
PBF Energy Inc.
Refining (high beta)
~$5B
—
Most leveraged to crack spreads
Hold; PT —
LNG
Cheniere Energy, Inc.
LNG Export
~$55B
—
Qatar LNG disruption
Buy; PT —
SLB
SLB Limited
Oilfield Services
~$60B
—
Non-Gulf supply build-out
Buy; PT —
HAL
Halliburton Company
Oilfield Services
~$25B
—
North American activity
Buy; PT —
MEOH
Methanex Corporation
Chemicals / Methanol
~$5B
—
+14.04% to 71.57 on the week
Buy; PT —
ETFs
XLE · XOP · OIH · CRAK · USO
What type of market are we in: Bearish, big sell off yesterday weakness has spread from the Tech & AI trade to the rest of the market. A +1200 selling day on 4% bearish study, which will likely lead to a bear market rally in the coming days.
Key things for this week: Nov 3: US midterm elections, with a possible shift in Congressional control; Nov 6: October nonfarm payrolls and unemployment rate; and AMD reports on 3 Nov. A tech bounce after AMD would be the main threat to the healthcare rotation.
Are breakouts working: No
Are breakouts likely to work for the next 3 – 5 days: No, market would favour quicker trades if we get a bear market rally,
Are breakdowns likely to work for the next 3 – 5 days: No, also too risky at these levels after such a big flush down.
Should I be trading: Only short term bounce trades using 5m ROE
Todays watchlist (stocks setting up): None at the moment